U.S. flag

An official website of the United States government

NM_000497.4(CYP11B1):c.124C>T (p.Pro42Ser) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 31, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001851529.3

Allele description [Variation Report for NM_000497.4(CYP11B1):c.124C>T (p.Pro42Ser)]

NM_000497.4(CYP11B1):c.124C>T (p.Pro42Ser)

Gene:
CYP11B1:cytochrome P450 family 11 subfamily B member 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
8q24.3
Genomic location:
Preferred name:
NM_000497.4(CYP11B1):c.124C>T (p.Pro42Ser)
HGVS:
  • NC_000008.11:g.142879690G>A
  • NG_007954.1:g.5131C>T
  • NG_055454.1:g.68G>A
  • NM_000497.4:c.124C>TMANE SELECT
  • NM_001026213.1:c.124C>T
  • NP_000488.3:p.Pro42Ser
  • NP_000488.3:p.Pro42Ser
  • NP_001021384.1:p.Pro42Ser
  • NC_000008.10:g.143961106G>A
  • NM_000497.3:c.124C>T
  • P15538:p.Pro42Ser
Protein change:
P42S; PRO42SER
Links:
UniProtKB: P15538#VAR_001260; OMIM: 610613.0009; dbSNP: rs104894069
NCBI 1000 Genomes Browser:
rs104894069
Molecular consequence:
  • NM_000497.4:c.124C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001026213.1:c.124C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002128982Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jan 31, 2024)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

CYP11B1 mutations causing non-classic adrenal hyperplasia due to 11 beta-hydroxylase deficiency.

Joehrer K, Geley S, Strasser-Wozak EM, Azziz R, Wollmann HA, Schmitt K, Kofler R, White PC.

Hum Mol Genet. 1997 Oct;6(11):1829-34.

PubMed [citation]
PMID:
9302260

Characterization of the molecular genetic pathology in patients with 11β-hydroxylase deficiency.

Mooij CF, Parajes S, Rose IT, Taylor AE, Bayraktaroglu T, Wass JA, Connell JM, Ray DW, Arlt W, Krone N.

Clin Endocrinol (Oxf). 2015 Nov;83(5):629-35. doi: 10.1111/cen.12834. Epub 2015 Jul 14.

PubMed [citation]
PMID:
26053152
See all PubMed Citations (3)

Details of each submission

From Invitae, SCV002128982.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 42 of the CYP11B1 protein (p.Pro42Ser). This variant is present in population databases (rs104894069, gnomAD 0.004%). This missense change has been observed in individual(s) with congenital adrenal hyperplasia (PMID: 9302260). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 1179). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CYP11B1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects CYP11B1 function (PMID: 9302260, 26053152). This variant disrupts the p.Pro42 amino acid residue in CYP11B1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 26053152; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024